Publications by authors named "Akimi Akashi"

Claim this Profile
C
Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells.
Naomi Kawashima, Yuichi Ishikawa, Jeong Hui Kim, Yoko Ushijima, Akimi Akashi, Marie Nakashima

Nat Commun· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia.
Hikaru Hattori, Yuichi Ishikawa, Naomi Kawashima, Akimi Akashi, Yohei Yamaguchi

PLoS One· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study.
Naomi Kawashima, Akimi Akashi, Yasunobu Nagata, Rika Kihara, Yuichi Ishikawa

Ann Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation analysis of therapy-related myeloid neoplasms.
Takahiro Nishiyama, Yuichi Ishikawa, Naomi Kawashima, Akimi Akashi, Yoshiya Adachi

Cancer Genet· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with mutations.
Takeshi Yamaura, Toshiyuki Nakatani, Ken Uda, Hayato Ogura, Wigyon Shin, Akimi Akashi

Blood· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes.
Yasuhiro Suzuki, Akihiro Tomita, Fumika Nakamura, Chisako Iriyama, Mizuho Shirahata-Adachi, Akimi Akashi

Cancer Sci· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells.
Fangli Chen, Yuichi Ishikawa, Akimi Akashi, Tomoki Naoe, Hitoshi Kiyoi

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis